XML 23 R13.htm IDEA: XBRL DOCUMENT v3.25.3
Intangible Assets
 9 Months Ended
Sep. 30, 2025
Intangible Assets, Net (Excluding Goodwill) [Abstract]  
Intangible Assets
6. Intangible Assets
The following table presents details of the Company’s acquired intangible assets as of September 30, 2025 and December 31, 2024 (in thousands):
As of September 30, 2025Gross Carrying AmountAccumulated AmortizationNet
Finite-lived intangible assets:
Customer relationships$6,997 $(3,848)$3,149 
Trade secrets and processes5,256 (2,037)3,219 
Total intangible assets $12,253 $(5,885)$6,368 
During the nine months ended September 30, 2025, the Company disposed of intangible assets related to its immersive healthcare business that had been previously impaired during the year ended December 31, 2024, resulting in the write-off of developed technology and the corresponding accumulated amortization of $83.3 million.
As of December 31, 2024Gross Carrying AmountAccumulated AmortizationNet
Finite-lived intangible assets:
Developed technology(1)
$83,289 $(83,289)$— 
Customer relationships6,192 (3,095)3,097 
Trade secrets and processes5,256 (1,840)3,416 
Total intangible assets$94,737 $(88,224)$6,513 
(1)During the year ended December 31, 2024, the Company recorded an impairment of developed technology charge of $58.9 million included within accumulated amortization in the table above. Refer to Note “4. Impairment and Restructuring Costs of Immersive Healthcare Asset Group” for more information.
The gross carrying amount and accumulated amortization of the customer relationships are the only intangible assets subject to foreign currency translation effects. The Company’s $5.3 million trade secrets and processes intangible asset was recognized in connection with a royalty buyout agreement in 2018.
The following table presents the amortization recorded related to the Company’s finite-lived intangible assets for the three and nine months ended September 30, 2025 and 2024 (in thousands):
 Three Months Ended September 30,Nine Months Ended September 30,
 2025202420252024
Cost of revenue$66 $66 $197 $197 
Sales, general and administrative(1)
116 110 333 5,083 
Total$182 $176 $530 $5,280 
(1)This does not include the impairment charge of $58.9 million related to the Company’s immersive healthcare developed technology during the three months ended June 30, 2024. Refer to Note “4. Impairment and Restructuring Costs of Immersive Healthcare Asset Group” for more information.